Top 10 BioTech Consulting/Service Companies - 2020

Biotechnology has created various advancements in plant and agri-biotechnology in preserving rare species, mutating species of commercial importance, and plays a major role in credentials to find the medical assessment thereby formulating naturopathic drugs. A broad venture in Animal biotechnology succours us to lead R&D. It paves the way for new reproduction techniques in animals and humans and explains the importance and usage of animal products and its presence in Biodiversity. In Medicinal Science, Biotechnology plays a critical role in immunotherapies, regeneration of organs, remedies for various neural disorders etc.

Endeavours in biomedical technology largely reinforce evolution in R&D. Technology developed for pollution is of immense value to the environment. Biotechnology employs multi-disciplinary efforts in the field of Physical sciences and Bioinformatics to analyzing, handling and studying big data for framing up new innovations for the benefit of the humans and our ecosystem.

As for most complex issues there is no single simple remedy. Biotechnology is not a panacea for world hunger. However, when combined with traditional breeding, good agricultural practice and sound economic policies it can be an important factor in achieving improved standards of health and economic security for all the world's people. Whether the new technologies can be effectively directed as those who need it most, or will only benefit the already affluent North remains a significant question. It essential that we do not proceed to a situation comparable to that for the treatment of AIDS where the costs of high technology cures make them applicable only to the those infected in the North and has completely failed to address the epidemic as a whole, providing no hope to victims in the LDCs where the disease is spiraling out of control.

Biotechnology is still in its infancy to find the answers of nature, understand the power beyond science, such as hydrogen and oxygen giving us water. Biotechnology has its own advantage and disadvantage Biotechnologists must be able to handle the society and address the controversial aspects of bringing a technology or a product in use. Competition in biotech shows no signs of slowing down anytime soon. Staying ahead of the pack requires strategic thinking, with a focus on establishing systems for reducing risk and ensuring quality. For some companies, it’s a big step, but it’s one that will pay off in the long run.

We present to you, “10 Most Promising BioTech Consulting/Service Companies - 2020.”

Top BioTech Consulting/Service Companies

Altasciences’ intelligent drug development platform demonstrates how integration stems from the operational structure and branches out into each phase of drug development. The platform applies parallel processing, high quality data, and anticipates potential roadblocks, for a program that easily and quickly adapts, saving clients time and money. A dedicated cross-functional project manager and single scheduling system works with the client throughout their journey. The project manager acts as a liaison between the client and Altasciences, and between scientific teams within Altasciences.

Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp

Adaptive Biotechnologies is a pioneer and leader in immune-driven medicine that aims to improve people’s lives by learning from the wisdom of their adaptive immune systems. Adaptive’s proprietary immune profiling platform reveals and translates insights from our adaptive immune systems with unprecedented scale and precision. Working with drug developers, clinicians and academic researchers, they are applying these insights to develop products that will transform the way diseases -- such as cancer, autoimmune conditions, and infectious diseases -- are diagnosed and treated.

ArcherDX, Inc.

ArcherDX, Inc.

ArcherDX, Inc., creates catalog and custom next-generation sequencing (NGS) assays that are purpose-built to identify mutations and gene fusions from clinical sample types. By combining novel enrichment chemistry, automated informatics and a user-friendly workflow, Archer® products remove the bottlenecks associated with using next-gen sequencing in a translational setting. The firm’s suite of products and services are highly accurate, personal and easy to use in local settings.

Celularity

Celularity

Celularity is fundamentally altering how we approach the treatment of Cancer, Infectious Diseases, and Degenerative Diseases through continuous, innovative application of new discoveries in cellular medicine. The firm’s mission is to lead the next evolution in cellular medicine by delivering off-the-shelf allogeneic cellular therapies, at unparalleled scale, quality, and economics. A next-generation Biotechnology company creating off-the-shelf cellular medicines for Cancer, Infectious Diseases, and Degenerative Diseases.

Digital Infuzion

Digital Infuzion

Digital Infuzion is a software and health care IT company. At Digital Infuzion, they strive to revolutionize the health care industry by utilizing biomedical informatics in such a way that health organizations, medical professionals, and researchers can make more accurate and more inspired decisions. By creating software that provides life-saving insights, we do our small part in not only improving patients’ lives and their futures, but all lives affected by disease.

Inscripta

Inscripta

Inscripta is developing the world’s first benchtop platform for scalable digital genome engineering. The company’s advanced CRISPR-based platform, consisting of an instrument, consumables, software, and assays, offers a fully automated workflow that enables massively parallel, trackable editing of single cells at an unprecedented scale. Inscripta’s goal is to empower scientists whose gene editing research is stifled by current technical and licensing limitations.

LakePharma, Inc

LakePharma, Inc

LakePharma is a US-based Biologics CRDMO with operations in CA, MA, and TX that provides integrated solutions ranging from discovery to engineering, development, and GMP manufacturing. The company specializes in the production and evaluation of antibodies, DNA vectors, viral vectors, cell lines, proteins, and conjugates. LakePharma has contributed to the development of 200+ therapeutic or diagnostic products and strives to contribute to hundreds more.

Tempus

Tempus

Tempus is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for patients, physicians, and researchers. Tempus is making precision medicine a reality by applying AI in healthcare, deriving insights from our expansive library of clinical data and molecular data. They enable physicians to make real-time, data-driven decisions to deliver personalized care and targeted therapies for patients through their analytical machine learning platform that uses the power of artificial intelligence in healthcare.

Tunnell Consulting

Tunnell Consulting

Tunnell Consulting designs and implements sustainable solutions that improve the operating performance of each unique client they serve. Integrating technical, process and organizational skills, our proven problem-solving methodologies enable life science companies to achieve optimal compliance and quality performance, operational excellence and organizational effectiveness. Since their founding in 1962, their experienced professionals, representing a wide range of scientific, technical, analytical and business disciplines, have worked with leading life sciences companies to achieve increased efficiency and measurable results that show up on the top and bottom lines.

Voyager Therapeutics, Inc

Voyager Therapeutics, Inc

Voyager Therapeutics is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. Voyager is committed to advancing the field of AAV gene therapy through innovation and investment in vector engineering and optimization, manufacturing, and dosing and delivery techniques. Voyager’s wholly owned and partnered pipeline focuses on severe neurological diseases for which effective new therapies are needed, including Parkinson’s disease, Huntington’s disease, Friedreich’s ataxia, and other severe neurological diseases.